Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MDU Resources Group Inc. Common Stock (Holding Company) (MDU) vs Organon & Co. Common Stock (OGN) Price & Performance

MDU Resources Group Inc. Common Stock (Holding Company)Trade
Organon & Co. Common StockTrade

Price performance (Past 24H)

Key statistics

MDU Resources Group Inc. Common Stock (Holding Company) vs Organon & Co. Common Stock — how do they compare? MDU Resources Group Inc. Common Stock (Holding Company) trades at $18.56 (market cap $3.92B), while Organon & Co. Common Stock trades at $13.58 (market cap $3.62B). The key difference: MDU Resources Group Inc. Common Stock (Holding Company) and Organon & Co. Common Stock are close in size by market cap, and MDU Resources Group Inc. Common Stock (Holding Company) pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold MDU Resources Group Inc. Common Stock (Holding Company) for 0 Days and Organon & Co. Common Stock for 0 Days on average.

MDUOGN
Market Cap
$3.92B$3.62B
Volume
1,027,6562,892,999
Sector
UtilitiesHealth
52-Week High
$22.80$13.81
52-Week Low
$18.39$5.70
Typical Hold Time
0 Days0 Days
Enterprise Value
$6.45B$11.04B
Dividend Yield
3.03%0.58%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MDU Resources Group Inc. Common Stock (Holding Company)

No Aura AI signal available yet.

Organon & Co. Common Stock

Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.

OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MDU
100% Buy0% Sell
Avg holding period · 0 Days
OGN
100% Buy0% Sell
Avg holding period · 0 Days

About MDU Resources Group Inc. Common Stock (Holding Company)

MDU Resources Group, Inc. is a US holding company operating regulated electric and natural gas utility services alongside a construction materials and services business supplying asphalt, concrete, and aggregates.

Read more on MDU →

About Organon & Co. Common Stock

Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.

Read more on OGN →